Evolutionary Genomics, Inc. Accounts Receivable
Evolutionary Genomics, Inc. had Accounts Receivable of $6.84 thousand as of 2019-12-31, per its 10-K filed 2021-03-31.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2021-03-31
- 2019-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $6.84K.
- 2019-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $32.72K.
- 2019-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $50.75K.
- 2019-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $32.37K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2019-12-31 | $6.84K 10-K · filed 2021-03-31 |
| 2019-09-30 | $32.72K 10-Q · filed 2019-10-17 |
| 2019-06-30 | $50.75K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $32.37K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $40.44K 10-K · filed 2020-03-30 |
| 2018-09-30 | $51.38K 10-Q · filed 2018-11-14 |
| 2017-03-31 | $26.68K 10-Q · filed 2017-05-11 |
| 2016-12-31 | $9.29K 10-K · filed 2018-03-05 |
| 2016-09-30 | $31.83K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $49.29K 10-Q · filed 2016-08-12 |
| 2016-03-31 | $18.96K 10-Q · filed 2016-05-11 |
| 2015-12-31 | $16.15K 10-K · filed 2017-02-10 |
| 2014-12-31 | $40.63K 10-K · filed 2016-02-19 |